	US 12,351,813 B2
	Tetracycline-inducible expression system
Jeremy Minshull, Los Altos, CA (US)
Assigned to DNA TWOPOINTO INC., Newark, CA (US)
Filed by DNA TWOPOINTO INC., Newark, CA (US)
Filed on Dec. 16, 2022, as Appl. No. 18/067,686.
Application 18/067,686 is a continuation of application No. 17/700,405, filed on Mar. 21, 2022, granted, now 11,566,262.
Claims priority of provisional application 63/165,484, filed on Mar. 24, 2021.
Prior Publication US 2023/0323396 A1, Oct. 12, 2023
Int. Cl. C12N 15/86 (2006.01); A01K 67/0275 (2024.01); A61K 48/00 (2006.01); C12N 5/071 (2010.01); C12N 15/85 (2006.01)

CPC C12N 15/86 (2013.01) [A01K 67/0275 (2013.01); A61K 48/0066 (2013.01); C12N 5/0682 (2013.01); C12N 15/8509 (2013.01); A01K 2217/05 (2013.01); A01K 2217/203 (2013.01); A01K 2227/105 (2013.01); C12N 2710/16142 (2013.01); C12N 2800/90 (2013.01); C12N 2830/003 (2013.01); C12N 2830/50 (2013.01)]

29 Claims

1. A nucleic acid comprising a transcriptional unit comprising a hybrid mouse-human CMV promoter having a sequence comprising SEQ ID NO:10 in operable linkage with a coding segment.